The $2.1 million question: what are the medical, ethical implications of the world's priciest drug?

10 June 2019 - With last month’s FDA approval, Zolgensma became the world’s most expensive medication.  ...

Read more →

ALP cancer plan ‘divisive, inequitable’

11 April 2019 - Labor’s decision to prioritise fee relief for cancer patients is a departure from its previous policies ...

Read more →

Frustrated at cancer treatment inequity

13 December 2018 - As appointed ambassador for the Lung Foundation NZ, I feel very frustrated the Government will not ...

Read more →

Health system neglects vulnerable Australians: Grattan Institute report

30 July 2018 - Vulnerable Australians are being neglected by a primary health system that is poorly integrated, lacks direction ...

Read more →

Tackling inequalities to improve wellbeing in New Zealand

28 July 2018 - In May, 2018, Jacinda Ardern's New Zealand Government announced their first budget and, in a world first, ...

Read more →

Mission possible: moving the needle forward to advance health equity

26 April 2018 - Every April our country observes National Minority Health Month to spotlight what we’re doing to eliminate health ...

Read more →

WA accuses Canberra of $1 billion health care rip-off

16 April 2018 - West Australians are missing out on $1 billion in federal health funding in a "Canberra rip-off", ...

Read more →

PHARMAC commits to equity target by 2025

7 December 2017 - Achieving equity in medicines access is one of the bold goals PHARMAC has set itself to ...

Read more →

America is a world leader in health inequality

5 June 2017 - The divide between health outcomes for the richest and poorest Americans is among the largest in ...

Read more →

Redistribution and redesign in health care: an ebbing tide in England versus growing concerns in the United States

4 May 2017 - Like many countries, the health care industries of England  and the United States consume large amounts ...

Read more →

Trading health care for the poor for tax cuts for the rich

13 March 2017 - So much for President Trump’s pledge of “insurance for everybody.” ...

Read more →

A comprehensive and fair solution to the price of medicines

5 July 2016 - After a long dry spell, the pharmaceutical research industry has brought to market a spate of ...

Read more →

Why the WHO plans a fair pricing model for drugs

7 July 2016 - Over the next year, the World Health Organization wants to develop a fair pricing model for pharmaceuticals. ...

Read more →

Accelerated drug approval and health inequality

5 July 2016 - This Viewpoint argues that the acceleration of the drug approval process could unequally distribute the costs and ...

Read more →

Why cancer?

14 June 2016 - Throughout my career as a health economist, one issue has always been a mystery to me—why does ...

Read more →